Login
- Document type:
- Journal Article
- Author(s):
- Rammes, G; Schierloh, A
- Title:
- Neramexane (merz pharmaceuticals/forest laboratories).
- Abstract:
- Merz Pharmaceuticals GmbH and Forest Laboratories Inc are developing neramexane, an oral N-methyl-D-aspartate antagonist, as a potential neuroprotectant for various central nervous system disorders, including Alzheimer's disease, and for the potential treatment of drug and alcohol dependence, and pain.
- Journal title abbreviation:
- IDrugs
- Year:
- 2006
- Journal volume:
- 9
- Journal issue:
- 2
- Pages contribution:
- 128-35
- Language:
- eng
- Pubmed ID:
- http://view.ncbi.nlm.nih.gov/pubmed/16523403
- Print-ISSN:
- 1369-7056
- TUM Institution:
- Klinik für Anästhesiologie (DHM)
BibTeX